Pnc Financial Services Group, Inc. 4 D Molecular Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 5,494 shares of FDMT stock, worth $32,084. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,494
Previous 4,360
26.01%
Holding current value
$32,084
Previous $91,000
35.16%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$43.1 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$29.8 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$28.6 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$25.7 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$23.9 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $189M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...